Please login to the form below

Not currently logged in
Email:
Password:

Kleemann joins Merck from Boehringer

Appointed head of group tax

Pharma finance veteran Sylvia Kleemann is to leave Boehringer Ingelheim to join rival German pharma firm Merck KGaA as head of group tax at the beginning of 2014.

Kleeman served as head of corporate tax at Boehringer and has additional life sciences experience at KPMG, Celanese and Fresenius Medical Care.

In her new role, she will report to chief financial officer Matthias Zachert. She replaces Armin Gembruch who has been head of group tax since May 2011.

Zachert said: “Sylvia Kleemann has extensive experience in both the pharmaceutical and the chemical industries. At the same time, Sylvia Kleemann has a very broad understanding of both public and family-owned companies, which makes her ideally suited for her new position at Merck.”

3rd December 2013

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Fishawack Health

Fishawack Health is the leading global commercialization partner for the modern life science era. Established in 2001 and headquartered in...

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...